Abstract
The management of bioprosthetic structural valve degeneration requires complex surgical or transcatheter re-intervention for which many high-risk patients are not considered candidates. Here, we describe a technique for a direct surgical access valve-in-valve implantation in patients with complex bioprosthetic valvulopathy for whom standard surgical valve replacement and percutaneous interventions were high-risk and contraindicated, respectively.
Keywords:
aortic valve disease (AVD); interventional devices/innovation (IDI); mitral valve disease (MVD); structural heart disease intervention (SHDI); surgery; transcatheter valve implantation (TVI); valvular (SVAL).
© 2019 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals, Inc.
Publication types
-
Case Reports
-
Video-Audio Media
MeSH terms
-
Aged
-
Aged, 80 and over
-
Aortic Valve / diagnostic imaging
-
Aortic Valve / physiopathology
-
Aortic Valve / surgery*
-
Aortic Valve Stenosis / diagnostic imaging
-
Aortic Valve Stenosis / physiopathology
-
Aortic Valve Stenosis / surgery*
-
Bioprosthesis*
-
Cardiac Catheterization / instrumentation*
-
Female
-
Heart Valve Prosthesis Implantation / adverse effects
-
Heart Valve Prosthesis Implantation / instrumentation*
-
Heart Valve Prosthesis*
-
Hemodynamics
-
Humans
-
Mitral Valve / diagnostic imaging
-
Mitral Valve / physiopathology
-
Mitral Valve / surgery*
-
Mitral Valve Insufficiency / diagnostic imaging
-
Mitral Valve Insufficiency / physiopathology
-
Mitral Valve Insufficiency / surgery*
-
Prosthesis Design
-
Prosthesis Failure*
-
Recovery of Function
-
Transcatheter Aortic Valve Replacement / instrumentation*
-
Treatment Outcome